Perigon Wealth Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$883K Buy
20,692
+5,258
+34% +$286K 0.01% 636
2026
Q1
$968K Sell
15,434
-608
-4% -$48.6K 0.02% 548
2025
Q4
$1.53M Sell
16,042
-509
-3% -$49.9K 0.03% 432
2025
Q3
$1.62M Buy
16,551
+2,625
+19% +$272K 0.03% 400
2025
Q2
$1.5M Buy
13,926
+394
+3% +$39.9K 0.03% 392
2025
Q1
$1.37M Buy
13,532
+996
+8% +$100K 0.04% 382
2024
Q4
$1.23M Sell
12,536
-3,987
-24% -$351K 0.03% 398
2024
Q3
$1.38M Buy
16,523
+5,544
+50% +$437K 0.04% 356
2024
Q2
$845K Sell
10,979
-202
-2% -$14.8K 0.02% 409
2024
Q1
$766K Buy
11,181
+311
+3% +$20K 0.02% 430
2023
Q4
$628K Sell
10,870
-660
-6% -$35.2K 0.02% 440
2023
Q3
$609K Buy
11,530
+538
+5% +$28.2K 0.02% 398
2023
Q2
$595K Buy
10,992
+2,652
+32% +$139K 0.02% 415
2023
Q1
$417K Buy
8,340
+371
+5% +$17.5K 0.02% 436
2022
Q4
$369K Buy
7,969
+1,494
+23% +$64.7K 0.02% 468
2022
Q3
$251K Buy
+6,475
New +$260K 0.02% 473
2021
Q1
Sell
-2,176
Closed -$78K 563
2020
Q4
$78K Buy
+2,176
New +$78.4K 0.01% 604
2018
Q2
Sell
-28
Closed -$1K 285
2018
Q1
$1K Buy
+28
New +$761 ﹤0.01% 608

Other funds holding BSX

Perigon Wealth Management's BSX Position: Q2 2026 in Review

Perigon Wealth Management increased its Boston Scientific (BSX) stake by 34% in Q2 2026, buying an estimated $286K and bringing the position to 20,692 shares worth $883K. The position accounts for 0.01% of the portfolio, ranked #636.

Perigon Wealth Management first reported a position in BSX in Q1 2018 and has held it in 18 quarters since. The position peaked at $1.62M in Q3 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Perigon Wealth Management held 20,692 shares of Boston Scientific worth $883K as of Q2 2026.
  • Perigon Wealth Management bought 5,258 Boston Scientific shares in Q2 2026, an estimated $286K.
  • Boston Scientific made up 0.01% of Perigon Wealth Management's portfolio in Q2 2026, its #636 holding.
  • Perigon Wealth Management first reported a position in Boston Scientific in Q1 2018 and has held it in 18 quarters since.
  • Perigon Wealth Management's Boston Scientific position peaked at $1.62M in Q3 2025.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Perigon Wealth Management's 13F filing for Q2 2026, filed 7 Aug 2026.